Author

Huanyu Dou

Unknown affiliation - Cited by 3,102

Biography

Huanyu Dou is affiliated to Department of Biomedical Sciences, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, Texas, USA . He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study.  His research interests reflect in his wide range of publications in various national and international journals.
Title
Cited by
Year
Nanotechnology: a focus on nanoparticles as a drug delivery system
JD Kingsley, H Dou, J Morehead, B Rabinow, HE Gendelman, ...Journal of Neuroimmune Pharmacology 1, 340-350, 2006200
347
2006
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery
H Dou, CJ Destache, JR Morehead, RL Mosley, MD Boska, J Kingsley, ...Blood 108 (8), 2827-5, 2006200
283
2006
Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS
H Dou, CB Grotepas, JEM McMillan, CJ Destache, M Chaubal, J Werling, ...The Journal of immunology 183 (1), 661-669, 2009200
235
2009
Immune modulation by volatile anesthetics
LM Stollings, LJ Jia, P Tang, H Dou, B Lu, Y XuAnesthesiology 125 (2), 399-411, 2016201
215
2016
Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles
A Beduneau, Z Ma, CB Grotepas, A Kabanov, BE Rabinow, N Gong, ...PloS one 4 (2), e4343, 2009200
158
2009
NanoART synthesis, characterization, uptake, release and toxicology for human monocyte–macrophage drug delivery
AS Nowacek, RL Miller, JE McMillan, G Kanmogne, M Kanmogne, ...Nanomedicine 4 (8), 903-917, 2009200
132
2009
Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages
H Dou, J Morehead, CJ Destache, JD Kingsley, L Shlyakhtenko, Y Zhou, ...Virology 358 (1), 148-158, 2007200
107
2007
HIV‐1‐infected and/or immune‐activated macrophage‐secreted TNF‐α affects human fetal cortical neural progenitor cell proliferation and differentiation
H Peng, N Whitney, Y Wu, C Tian, H Dou, Y Zhou, J ZhengGlia 56 (8), 903-6, 2008200
91
2008
Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy
L Quan, PE Purdue, X Liu, MD Boska, SM Lele, GM Thiele, TR Mikuls, ...Arthritis research & therapy 12, 1-10, 2010201
73
2010
Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery
S Gorantla, H Dou, M Boska, CJ Destache, J Nelson, L Poluektova, ...Journal of Leukocyte Biology 80 (5), 1165-1174, 2006200
69
2006
Nanoerythropoietin is 10-times more effective than regular erythropoietin in neuroprotection in a neonatal rat model of hypoxia and ischemia
H Chen, F Spagnoli, M Burris, WB Rolland, A Fajilan, H Dou, J Tang, ...Stroke 43 (3), 884-887, 2012201
56
2012
Neuroprotective activities of CEP-1347 in models of neuroAIDS
D Eggert, PK Dash, S Gorantla, H Dou, G Schifitto, SB Maggirwar, ...The journal of immunology 184 (2), 746-756, 2010201
54
2010
Nano-formulation of paclitaxel by vitamin E succinate functionalized pluronic micelles for enhanced encapsulation, stability and cytotoxicity
Y Tao, J Han, X Wang, H DouColloids and Surfaces B: Biointerfaces 102, 604-610, 2013201
49
2013
Reduction-responsive gold-nanoparticle-conjugated Pluronic micelles: an effective anti-cancer drug delivery system
Y Tao, J Han, C Ye, T Thomas, H DouJournal of Materials Chemistry 22 (36), 18864-18871, 2012201
45
2012
Brain-targeting gene delivery using a rabies virus glycoprotein peptide modulated hollow liposome: bio-behavioral study
Y Tao, J Han, H DouJournal of Materials Chemistry 22 (23), 11808-11815, 2012201
44
2012
Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis
S Gorantla, J Liu, H Sneller, H Dou, A Holguin, L Smith, T Ikezu, DJ Volsky, ...The Journal of Immunology 179 (7), 45-56, 2007200
43
2007
PPARγ activation suppresses HIV-1 replication in an animal model of encephalitis
R Potula, SH Ramirez, B Knipe, J Leibhart, K Schall, D Heilman, B Morsey, ...AIDS (London, England) 22 (13), 1539, 2008200
43
2008
Targeted delivery of nano-PTX to the brain tumor-associated macrophages
L Zou, Y Tao, G Payne, L Do, T Thomas, J Rodriguez, H DouOncotarget 8 (4), 6564, 2017201
41
2017
Paclitaxel-loaded tocopheryl succinate-conjugated chitosan oligosaccharide nanoparticles for synergistic chemotherapy
Y Tao, J Han, H DouJournal of Materials Chemistry 22 (18), 8930-89, 2012201
37
2012
Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders
D Eggert, PK Dash, N Serradji, CZ Dong, P Clayette, F Heymans, H Dou, ...Journal of neuroimmunology 213 (1-2), 47-59, 2009200
37
2009

Referred From: https://scholar.google.com/citations?user=-LafTpAAAAAJ&hl=en

Cited by
Citations 3102
h-index 30
i10-index 38
Open Access Journals